Abvc Biopharma (ABVC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.92, -1.62% vs the prior close of $0.93.
- Volume 29.20K shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ABVC dips 1.6% to $0.92, a 1-month low. Closed at $0.92, -1.62% vs the prior close of $0.93. Day range $0.90–$0.94, opened at $0.91.
ABVC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ABVC dips 1.6% to $0.92, a 1-month low
- Closed at $0.92, -1.62% vs the prior close of $0.93. Day range $0.90–$0.94, opened at $0.91.
- Volume was 29.20K shares, 0.3x its 50-day average of 114.88K — lighter than usual.
- Price is -5.9% vs its 50-day average ($0.97) and -30.2% vs its 200-day average ($1.32).
- 52-week range $0.71–$3.07; today's close sits at 9% of that range, 70.1% below the 52-week high.
Oct 15, 2026 — ABVC slides 8.5% to $0.93, a 1-month low
- Closed at $0.93, -8.53% vs the prior close of $1.02. Day range $0.92–$1.05, opened at $1.03.
- Volume was 104.80K shares, 0.9x its 50-day average of 115.06K.
- Price is -4.5% vs its 50-day average ($0.98) and -29.4% vs its 200-day average ($1.32).
- 52-week range $0.71–$3.07; today's close sits at 10% of that range, 69.6% below the 52-week high.
Oct 14, 2026 — ABVC jumps 4.2% to $1.02
- Closed at $1.02, +4.19% vs the prior close of $0.98. Day range $0.96–$1.03, opened at $1.00.
- Volume was 55.90K shares, 0.5x its 50-day average of 117.01K — lighter than usual.
- Price is +4.2% vs its 50-day average ($0.98) and -23.2% vs its 200-day average ($1.33).
- 52-week range $0.71–$3.07; today's close sits at 13% of that range, 66.8% below the 52-week high.
Oct 13, 2026 — ABVC ends flat (-0.1%) to $0.98
- Closed at $0.98, -0.10% vs the prior close of $0.98. Day range $0.96–$1.02, opened at $1.00.
- Volume was 120.00K shares, 1.0x its 50-day average of 115.97K.
- Price is -0.1% vs its 50-day average ($0.98) and -26.7% vs its 200-day average ($1.34).
- 52-week range $0.71–$3.16; today's close sits at 11% of that range, 69.0% below the 52-week high.
Oct 12, 2026 — ABVC dips 2.0% to $0.98
- Closed at $0.98, -2.00% vs the prior close of $1.00. Day range $0.97–$1.03, opened at $1.03.
- Volume was 95.90K shares, 0.8x its 50-day average of 114.56K.
- Price is -0.1% vs its 50-day average ($0.98) and -27.0% vs its 200-day average ($1.34).
- 52-week range $0.71–$3.33; today's close sits at 10% of that range, 70.5% below the 52-week high.
Oct 9, 2026 — ABVC rises 2.0% to $1.00
- Closed at $1.00, +2.04% vs the prior close of $0.98. Day range $0.98–$1.01, opened at $1.01.
- Volume was 41.50K shares, 0.4x its 50-day average of 116.11K — lighter than usual.
- Price is +1.9% vs its 50-day average ($0.98) and -25.9% vs its 200-day average ($1.35).
- 52-week range $0.71–$3.33; today's close sits at 11% of that range, 70.0% below the 52-week high.
Oct 8, 2026 — ABVC dips 2.0% to $0.98
- Closed at $0.98, -2.00% vs the prior close of $1.00. Day range $0.98–$1.05, opened at $1.03.
- Volume was 45.20K shares, 0.4x its 50-day average of 116.10K — lighter than usual.
- Price is -0.3% vs its 50-day average ($0.98) and -27.7% vs its 200-day average ($1.36).
- 52-week range $0.71–$3.33; today's close sits at 10% of that range, 70.6% below the 52-week high.
Oct 7, 2026 — ABVC jumps 3.1% to $1.00
- Closed at $1.00, +3.09% vs the prior close of $0.97. Day range $0.94–$1.01, opened at $0.94.
- Volume was 52.70K shares, 0.5x its 50-day average of 116.24K — lighter than usual.
- Price is +1.7% vs its 50-day average ($0.98) and -26.6% vs its 200-day average ($1.36).
- 52-week range $0.71–$3.40; today's close sits at 11% of that range, 70.6% below the 52-week high.
Oct 6, 2026 — ABVC dips 1.0% to $0.97, 4 down days in a row
- Closed at $0.97, -1.02% vs the prior close of $0.98. Day range $0.93–$1.01, opened at $0.99.
- Volume was 92.40K shares, 0.8x its 50-day average of 116.86K.
- Price is -1.5% vs its 50-day average ($0.98) and -29.0% vs its 200-day average ($1.37).
- 52-week range $0.71–$3.40; today's close sits at 10% of that range, 71.5% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — ABVC dips 3.0% to $0.98, 3 down days in a row
- Closed at $0.98, -2.97% vs the prior close of $1.01. Day range $0.98–$1.02, opened at $1.01.
- Volume was 93.50K shares, 0.8x its 50-day average of 116.67K.
- Price is -0.6% vs its 50-day average ($0.99) and -28.6% vs its 200-day average ($1.37).
- 52-week range $0.71–$3.40; today's close sits at 10% of that range, 71.2% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — ABVC dips 1.0% to $1.01
- Closed at $1.01, -0.98% vs the prior close of $1.02. Day range $1.00–$1.08, opened at $1.03.
- Volume was 98.10K shares, 0.8x its 50-day average of 116.11K.
- Price is +2.1% vs its 50-day average ($0.99) and -26.7% vs its 200-day average ($1.38).
- 52-week range $0.71–$3.40; today's close sits at 11% of that range, 70.3% below the 52-week high.
ABVC latest news & SEC filings
Every SEC filing by or about ABVC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Sep 11, 2026 · Form PRER14A — PRER14A filing
PRER14A filing
Aug 27, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.01 — Completed an acquisition or sale of assets.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 25, 2026 · Form PRER14A — PRER14A filing
PRER14A filing
Aug 17, 2026 · Form 424B4 — Final prospectus with offering price
Final prospectus with offering price
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 17, 2026 · Form 424B4 — Final prospectus with offering price
Final prospectus with offering price
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 17, 2026 · Form 424B4 — Final prospectus with offering price
Final prospectus with offering price
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 17, 2026 · Form 424B4 — Final prospectus with offering price
Final prospectus with offering price
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 12, 2026 · Form PRER14A — PRER14A filing
PRER14A filing
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$736.93K (prior year -$2.26M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.03 (prior year -$0.13) (loss narrowed vs Jun 30, 2025)
Aug 12, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 8.01 — Reported other events the company considers important.
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 28, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Jul 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 4.01 — Changed its outside auditor.
Things to know before you trade ABVC
- Last results release: Mar 3, 2026 (8-K Item 2.02). Previous ones: Nov 3, 2025, Aug 14, 2025, May 1, 2025. Based on that rhythm, the next report is likely around Jun 2, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.69% (largest 8.5%).
- Liquidity: about 91.82K shares (≈$84.28K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.92 vs a range of $0.71–$3.07 (9% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Aug 27, 2026; 10-Q Aug 12, 2026; 8-K Aug 4, 2026.
- Share count: 26.65M shares outstanding (Aug 10, 2026), +13.2% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
ABVC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.91 | 0.94 | 0.90 | 0.92 | 29.20K |
| Oct 15, 2026 | 1.03 | 1.05 | 0.92 | 0.93 | 104.80K |
| Oct 14, 2026 | 1.00 | 1.03 | 0.96 | 1.02 | 55.90K |
| Oct 13, 2026 | 1.00 | 1.02 | 0.96 | 0.98 | 120.00K |
| Oct 12, 2026 | 1.03 | 1.03 | 0.97 | 0.98 | 95.90K |
| Oct 9, 2026 | 1.01 | 1.01 | 0.98 | 1.00 | 41.50K |
| Oct 8, 2026 | 1.03 | 1.05 | 0.98 | 0.98 | 45.20K |
| Oct 7, 2026 | 0.94 | 1.01 | 0.94 | 1.00 | 52.70K |
| Oct 6, 2026 | 0.99 | 1.01 | 0.93 | 0.97 | 92.40K |
| Oct 5, 2026 | 1.01 | 1.02 | 0.98 | 0.98 | 93.50K |
| Oct 2, 2026 | 1.03 | 1.08 | 1.00 | 1.01 | 98.10K |
| Oct 1, 2026 | 1.07 | 1.08 | 1.02 | 1.02 | 138.60K |
| Sep 30, 2026 | 1.06 | 1.09 | 1.04 | 1.06 | 55.20K |
| Sep 29, 2026 | 1.05 | 1.08 | 1.01 | 1.04 | 183.00K |
| Sep 28, 2026 | 1.13 | 1.14 | 1.03 | 1.05 | 73.90K |
| Sep 25, 2026 | 1.08 | 1.16 | 1.05 | 1.13 | 89.30K |
| Sep 24, 2026 | 1.15 | 1.18 | 1.09 | 1.09 | 64.10K |
| Sep 23, 2026 | 1.15 | 1.20 | 1.12 | 1.14 | 74.90K |
| Sep 22, 2026 | 1.16 | 1.20 | 1.12 | 1.16 | 91.60K |
| Sep 21, 2026 | 1.17 | 1.23 | 1.10 | 1.15 | 236.50K |
About Abvc Biopharma
Abvc Biopharma (ABVC) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in FREMONT, CA. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 1173313.
ABVC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
ABVC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-7.91M | -0.39 | $-2.99M |
| Dec 31, 2024 | $509.59K | $-4.90M | -0.42 | $-1.81M |
| Dec 31, 2023 | $152.43K | $-7.79M | -1.80 | $-4.19M |
| Dec 31, 2022 | $969.78K | $-16.42M | -5.19 | $-7.40M |
| Dec 31, 2021 | $355.80K | $-12.84M | -0.51 | $-7.60M |
Latest balance sheet: total assets $19.40M, total liabilities $7.13M, cash $31.94K (as of Jun 30, 2026).
ABVC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Mar 3, 2026 | 8-K Item 2.02 (results) | $1.42 |
| Nov 3, 2025 | 8-K Item 2.02 (results) | $2.96 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $3.04 |
| May 1, 2025 | 8-K Item 2.02 (results) | $1.03 |
| Apr 15, 2025 | 8-K Item 2.02 (results) | $0.89 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $0.55 |
| Aug 15, 2024 | 8-K Item 2.02 (results) | — |
| Mar 14, 2024 | 8-K Item 2.02 (results) | — |
| Nov 15, 2023 | 8-K Item 2.02 (results) | — |
| Jul 24, 2023 | 8-K Item 2.02 (results) | — |
| Mar 31, 2023 | 8-K Item 2.02 (results) | — |
| Mar 31, 2022 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ABVC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.